The global light therapy market size was valued at USD 1.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 4.6% from 2023 to 2030. According to estimates published by WHO in 2018, skin diseases affected approximately 900 million of the population globally. The increasing adoption of non-invasive treatments and the increasing prevalence of skin diseases are the drivers for the market. Moreover, the market players are involved in various strategic initiatives such as product launches, which are fostering the industry’s growth.
For instance, in June 2022, BioPhotas, Inc. announced a partnership with Ulta Beauty. This partnership is expected to meet the skincare need of customers across the U.S. in 55 different locations with the help of the Celluma PRO and Celluma ELITE models. These models are FDA-cleared to treat various conditions such as acne, wrinkles, and joint pains.
The COVID-19 pandemic had a moderate impact on the light therapy market due to stringent lockdowns, disrupted supply chains, and strain on hospitals, which led to reduced production and availability of light therapy devices. This was compounded by the decreased demand for these products due to lockdowns, consumer spending cuts, and the avoidance of hospitals and clinics for non-emergency reasons. The economic slowdown caused by the pandemic also contributed to a decline in consumer spending. However, the rise in online retail and e-commerce had a positive impact on the market.
The growing incidence of skin-related diseases, depressive disorders such as winter blues, and seasonal affective disorder, along with rapid technological advancements in healthcare, are driving the growth of the market. Clinical depression is a common mental health condition characterized by persistent feelings of sadness and a loss of interest in activities. It also causes physical symptoms such as fatigue, changes in appetite and sleep disorder, and lack of focus.
Depression is caused by a combination of genetic, biological, environmental, and psychological factors. As per the estimates of WHO in 2021, depression affected approximately 264 million people globally. According to the International Labor Organization, around 50% of the youth population was affected by depressive disorders due to COVID-19 and the lockdown, which in turn, increased the demand for light therapy devices.
In addition, increasing awareness amongst consumers regarding the benefits of light therapy devices is expected to further propel the market growth. Moreover, home-held devices are further propelling the demand for light therapy devices due to their properties such as portability, wireless communication, and dosage regulation.
Based on products, the market is segmented into lightbox, floor and desk lamps, hand-held devices for skin treatment, light visors, light therapy lamps, and dawn simulators. In 2022, the hand-held devices segment dominated the market with a revenue share of 26.7% and is expected to expand at the highest CAGR of over 5.3% during the forecast period. The segment is gaining popularity due to the product’s wide range of properties such as portability, efficient technology, and user-friendliness. They are used for skin treatment and utilize technologies such as ultrasonic waves and microcurrents to improve the appearance of the skin.
The light visor segment is expected to progress at a CAGR of 4.9% over the forecast period, which is attributed to the increase in the number of aircraft travelers that has led to various conditions, including insomnia, eye fatigue, and jet lag. This is due to changes in time zones and sleep patterns. It is portable and user-friendly that could be worn on the head. It regulates melatonin hormones and improves the circadian rhythms of the body.
Based on applications, the market is segmented into psoriasis, vitiligo, eczema, sleeping disorder, and SAD/Winter blues. The sleeping disorder segment held the largest market share of 23.4% in 2022. There are various conditions related to sleep disorders such as insomnia, hypersomnia, and sleep-disordered breathing. The aforesaid conditions are attributed to unhealthy lifestyles such as smoking, alcohol consumption, and more screen time.
The SAD/winter blues segment is expected to witness the fastest CAGR of 5.3% during the forecast period. This is attributed to more screen time and unhealthy lifestyles such as a lack of physical activities, an unhealthy diet, and staying indoors for longer periods during winter.
Based on light type, the market is segmented into blue light, red light, and white light. The blue light segment dominated the market in terms of a revenue share of 42.8% in 2022 and is also expected to witness the fastest CAGR of 5.1% over the forecast period. Blue light therapy is used to treat various conditions such as acne, skin disorder, depression, and seasonal affective disorder. The treatment session depending on the condition and treatment area varies from 15 minutes to 90 minutes.
According to the AAD association, 9,500 people in the U.S. are diagnosed with skin cancer on a daily basis and approximately 1 million people in the U.S. are suffering from melanoma. Studies suggest that blue light therapy is effective in treating melanoma, which is expected to drive the market demand for blue light therapy devices.
Based on end-use, the market is segmented into dermatology clinics and home healthcare. The home healthcare segment dominated the market with the highest revenue share of 54.7% in 2022. Increasing consumer awareness and technological advancements such as remote patient monitoring are driving the market. Dermatology clinics are expected to witness a significant CAGR over the forecast period, which is attributed to an increase in various healthcare expenditures post-pandemic.
Dermatology clinics are specialized in treating various skin-related conditions such as acne, eczema, psoriasis, and vitiligo. As per estimates by WHO, skin diseases affect almost 900 million people, which is expected to drive the market for dermatology clinics. Moreover, increasing adoption of non-invasive treatments, and technological advancements such as the use of laser technology are expected to drive market growth over the forecast period.
North America dominated with the highest revenue share of 36.3% in 2022, owing to rising cases of SAD/Winter blues symptoms and psoriasis condition. Light therapy involves exposing the skin to ultraviolet light from artificial sources under medical supervision. UVB and UVA light, or a combination of both, are used to reduce inflammation, slow down skin cell growth, and improve symptoms. As per estimates by the Canadian Dermatology Association, approximately 1 million people have psoriasis condition, which is increasing the market for the devices.
The Asia Pacific region is expected to expand with the fastest CAGR of 5.6%, due to an increase in awareness about the benefits of light therapy, and increased investments in telemedicine. In addition, the increasing adoption of light therapy devices in hospitals, clinics, and the home care segment is also driving growth. The market is expected to continue growing in the coming years, driven by the increasing prevalence of sleep disorders, and the rising adoption of light therapy devices in the treatment of skin conditions such as acne, psoriasis, and eczema.
Europe is expected to have a CAGR of 4.6% over the forecast period; this is attributed to the prevalence of various skin conditions such as psoriasis, acne, and vitiligo in the region. Moreover, increasing cases of SAD and winter blues in the region are further driving the demand. The market is driven by increasing awareness about the benefits of light therapy in treating seasonal affective disorder (SAD) and other mood disorders. Additionally, the rising adoption of light therapy devices in the homecare segment and the growing number of people suffering from SAD and other mood disorders are also driving the market growth.
The key players are undertaking some strategies such as new product launches, mergers, collaborations, partnerships, and acquisitions to improve their market position. Several players are attempting to put demand-friendly strategic plans into action. In June 2022, BioPhotas, Inc. announced the development of a new battery-powered device that is capable of treating various skin, joint, and muscle conditions. This series has improved the efficiency of the product and allowed customers to use it anywhere, including the pool area, locker room, and beach or sports field.
Zerigo Health has a mobile application that automatically calculates and prescribes dosage according to the patient’s condition. In addition, the company also has a GPS tracker that shows the progress and provides a 1-to-1 consultation. These associated advantages are some of the factors expected to propel growth. Some prominent players in the global light therapy market include:
Koninklijke Philips N.V.
Beurer GmbH
BioPhotas.
Northern Light Technologies
Lumie
Verilux, Inc
Zepter International
The Daylight Company
Zerigo Health
Naturebright
Report Attribute |
Details |
Market size value in 2023 |
USD 1.05 billion |
Revenue forecast in 2030 |
USD 1.44 billion |
Growth rate |
CAGR of 4.6% from 2023 to 2030 |
Base year for estimation |
2022 |
Actual estimates/Historic data |
2017 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD & CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors & trends |
Segments covered |
Product, application, light type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Koninklijke Philips N.V.; Beurer GmbH; BioPhotas; Northern Light Technologies; Lumie; Verilux, Inc.; Zepter International; The Daylight Company; Zerigo Health; Naturebright |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global light therapy market report based on product, application, light type, end-use, and region:
Product Outlook (Revenue, USD Million, 2017 - 2030)
Light Box
Floor and Desk Lamps
Handheld Devices for Skin Treatment
Light Visor
Dawn Simulator
Light Therapy Lamps
Application Outlook (Revenue, USD Million, 2017 - 2030)
Psoriasis
Vitiligo
Eczema
Acne Vulgaris
SAD/Winter Blues
Sleeping Disorders
Light Type Outlook (Revenue, USD Million, 2017 - 2030)
Blue Light
Red Light
White Light
End-use Outlook (Revenue, USD Million, 2017 - 2030)
Dermatology Clinics
Home Healthcare
Regional Outlook (Revenue, USD Million, 2017 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global light therapy market size was estimated at USD 0.958 billion in 2022 and is expected to reach USD 0.999 million in 2023.
b. The global light therapy market is expected to grow at a compound annual growth rate of 4.7% from 2022 to 2030 to reach USD 1.37 billion by 2030.
b. In 2022, North America dominated the market in terms of revenue share of 36.3%. The market's growth in the region is increasing due to various sleeping disorder and increasing investment in the region.
b. Some of the key market players are Koninklijke Philips N.V.,BeurerGmbH, BioPhotas. , Northern Light Technologies, Lumie
b. Increasing adoption of light therapy devices for the treatment of various medical conditions, such as seasonal affective disorder (SAD), insomnia, and psoriasis" Growing demand for non-invasive and drug-free treatments for mental health conditions, such as depression and anxiety.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."